{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:17:32Z","timestamp":1791299852017,"version":"4.1.0"},"reference-count":74,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2800,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytometry"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1002\/cyto.b.20383","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T00:46:42Z","timestamp":1196902002000},"page":"S11-S18","source":"Crossref","is-referenced-by-count":15,"title":["Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa"],"prefix":"10.1002","volume":"74B","author":[{"given":"Babafemi O.","family":"Taiwo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1002\/cyto.b.20383-BIB1","unstructured":"UNAIDS report on the global AIDS epidemic (May 2006). Available at http:\/\/www.unaids.org\/en\/HIV_data\/2006GlobalReport\/default.asp (accessed June 12, 2007)."},{"key":"10.1002\/cyto.b.20383-BIB2","doi-asserted-by":"crossref","first-page":"6058","DOI":"10.1073\/pnas.87.16.6058","article-title":"Preferential infection of CD4R memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals","volume":"87","author":"Schnittman","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1002\/cyto.b.20383-BIB3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S1471-4906(01)02039-7","article-title":"The mucosal immune system: Primary targets for HIV and AIDS","volume":"22","author":"Veazey","year":"2001","journal-title":"Trends Immunol"},{"key":"10.1002\/cyto.b.20383-BIB4","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1126\/science.280.5362.427","article-title":"Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection","volume":"280","author":"Veazey","year":"1998","journal-title":"Science"},{"key":"10.1002\/cyto.b.20383-BIB5","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1128\/JVI.74.23.11001-11007.2000","article-title":"Dynamics of CCR5 expression by CD4+ T cells in lymphoid tissues during simian immunodeficiency virus infection","volume":"74","author":"Veazey","year":"2000","journal-title":"JVirol"},{"key":"10.1002\/cyto.b.20383-BIB6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1086\/339295","article-title":"Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa","volume":"185","author":"Gottlieb","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB7","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"Rosenberg","year":"1997","journal-title":"Science"},{"key":"10.1002\/cyto.b.20383-BIB8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(02)09411-4","article-title":"Prognosis of HIV-1 infected drug patients starting highly active antiretroviral therapy: A collaborative analysis of prospective studies","volume":"360","author":"Egger","year":"2002","journal-title":"Lancet"},{"key":"10.1002\/cyto.b.20383-BIB9","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1002\/cyto.b.20383-BIB10","doi-asserted-by":"crossref","first-page":"810","DOI":"10.7326\/0003-4819-139-10-200311180-00008","article-title":"Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 \u00d7 109 cells\/L","volume":"139","author":"Wood","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1002\/cyto.b.20383-BIB11","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4+ T cell count and numbers of CD28+ CD4+ T cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB12","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1086\/379741","article-title":"Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-Infected patients who achieve durable virologic suppression: Longer follow-up of an observational cohort study","volume":"188","author":"Sterling","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB13","unstructured":"World Health Organisation. ARV treatment guidelines and technical and operational recommendations for ART ( 2006). Available at http:\/\/www.who.int\/hiv\/pub\/guidelines\/artadultguidelines.pdf (accessed August 17, 2007)."},{"key":"10.1002\/cyto.b.20383-BIB14","unstructured":"WHO Clinical Charts and Tables. Available at http:\/\/www.womenchildrenhiv.org\/wchiv?page=charts-00-00 (accessed August 22, 2007)."},{"key":"10.1002\/cyto.b.20383-BIB15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.158.1.9712001","article-title":"Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS","volume":"158","author":"Narita","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1002\/cyto.b.20383-BIB16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/375195a0","article-title":"HIV results in the frame: Antiviral therapy [letter]","volume":"375","author":"Phillips","year":"1995","journal-title":"Nature"},{"key":"10.1002\/cyto.b.20383-BIB17","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nm0298-208","article-title":"Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation","volume":"4","author":"Pakker","year":"1998","journal-title":"Nat Med"},{"key":"10.1002\/cyto.b.20383-BIB18","unstructured":"Riddler SA,Haubrich R,DiRienzo G,Peeples L,Powderly WG for the AIDS Clinical Trials Group 5142 Study Team. A prospective, randomized, phase III trial of NRTI-, PI-, and NNRTI-sparing regimens for initial treatment of HIV infection. In: ACTG 5142. XVI International AIDS Conference, Toronto. August 13-18, 2006. Abstract THLB0204."},{"key":"10.1002\/cyto.b.20383-BIB19","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1086\/425075","article-title":"Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy","volume":"190","author":"Smith","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/00002030-200108170-00008","article-title":"A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to >200 \u00d7 106\/l","volume":"15","author":"Koletar","year":"2001","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB21","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/374849","article-title":"Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: A prospective, multicenter, randomized study","volume":"36","author":"Vibhagool","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1086\/323898","article-title":"Clinical indicators of immune restoration following highly active antiretroviral therapy","volume":"34","author":"Clooney","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.aids.0000161769.06158.8a","article-title":"Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy","volume":"19","author":"Shelburne","year":"2005","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB24","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1086\/381450","article-title":"Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors","volume":"38","author":"Dieterich","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB25","unstructured":"WHO. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: Towards universal access. Recommendations for a public health approach. Available at http:\/\/www.who.int\/hiv\/pub\/guidelines\/pmtctguidelines3.pdf (accessed September 17, 2007)."},{"key":"10.1002\/cyto.b.20383-BIB26","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Eng J Med"},{"key":"10.1002\/cyto.b.20383-BIB27","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(06)68887-9","article-title":"CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in West Africa (Trivacan ANRS 1269 trial): A randomised trial","volume":"367","author":"Danel","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/cyto.b.20383-BIB28","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0140-6736(06)69117-4","article-title":"Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa. A longitudinal study","volume":"368","author":"Badri","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/cyto.b.20383-BIB29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1155\/1998\/153450","article-title":"Determination of T-lymphocyte subsets in a North African population (Tunisia): Establishment of normal ranges and results in HIV-infected individuals","volume":"14","author":"Feki","year":"1998","journal-title":"Dis Markers"},{"key":"10.1002\/cyto.b.20383-BIB30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1128\/CDLI.2.2.233-235.1995","article-title":"Hematological reference ranges among healthy Ugandans","volume":"2","author":"Tugume","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/CDLI.10.3.443-445.2003","article-title":"Immunohematological reference ranges for adults from the Central African Republic","volume":"10","author":"Menard","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00042560-199701010-00016","article-title":"T lymphocyte subset values among healthy Camerounians","volume":"14","author":"Zekeng","year":"1997","journal-title":"JAcquir Immne Defic Syndr Hum Retrovirol"},{"key":"10.1002\/cyto.b.20383-BIB33","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1128\/CDLI.11.5.930-935.2004","article-title":"Low CD4 lymphocyte values in human immunodeficiency virus negative adults in Botswana","volume":"11","author":"Bussmann","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB34","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/CDLI.6.3.410-414.1999","article-title":"Immunohematological reference ranges for adult Ethiopians","volume":"6","author":"Tsegaye","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB35","first-page":"144","article-title":"Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1 infected patients: Total lymphocyte count fluctuation and diurnal cycle are important","volume":"3","author":"Malone","year":"1990","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB36","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1086\/375346","article-title":"Human immuno-deficiency virus-1 RNA levels and CD4 lymphocyte counts during treatment for active tuberculosis, in South African patients","volume":"187","author":"Morris","year":"2003","journal-title":"JInfect Dis"},{"key":"10.1002\/cyto.b.20383-BIB37","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/095646249400500304","article-title":"CD4 lymphocyte numbers after splenectomy in patients infected with the human immunodeficiency virus","volume":"5","author":"Fairley","year":"1994","journal-title":"Int J STD AIDS"},{"key":"10.1002\/cyto.b.20383-BIB38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.qai.0000243125.98024.da","article-title":"CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria","volume":"43","author":"Van Geertruyden","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB39","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/apc.1998.12.619","article-title":"Coinfection with HTLV-I and HIV: Increase in HTLV-I-related outcomes but not accelerated HIV disease progression?","volume":"12","author":"Harrison","year":"1998","journal-title":"AIDS Patient Care STDS"},{"key":"10.1002\/cyto.b.20383-BIB40","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1469-0691.2004.00896.x","article-title":"CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae","volume":"10","author":"Schleicher","year":"2004","journal-title":"Clin Microbiol Infect"},{"key":"10.1002\/cyto.b.20383-BIB41","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy","volume":"32","author":"Gl\u00fcck","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1002\/cyto.b.20383-BIB42","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1056\/NEJM199302113280601","article-title":"Unexplained opportunistic infections and CD4+ T-lymphopenia without HIV infection. An investigation of cases in the United States","volume":"328","author":"Smith","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1002\/cyto.b.20383-BIB43","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2169\/internalmedicine.36.643","article-title":"Idiopathic CD4+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient","volume":"36","author":"Hanamura","year":"1997","journal-title":"Intern Med"},{"key":"10.1002\/cyto.b.20383-BIB44","first-page":"317","article-title":"Blood cell kinetics after a 385 cGy total body irradiation given to a CML patient for bone marrow transplantation","volume":"7","author":"Girinsky","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/cyto.b.20383-BIB45","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1111\/j.1532-5415.1994.tb06514.x","article-title":"Idiopathic CD4+ T lymphopenia in older persons","volume":"42","author":"Kaiser","year":"1994","journal-title":"J Am Geriatr Soc"},{"key":"10.1002\/cyto.b.20383-BIB46","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.aids.0000163933.14649.93","article-title":"Paradoxical CD4+ T cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine","volume":"19","author":"Barrios","year":"2005","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB47","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1097\/01.aids.0000238407.00874.dc","article-title":"Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy","volume":"20","author":"Bisson","year":"2006","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB48","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1089\/aid.2006.0298","article-title":"The 67N 70R 215Y TAM pathway in HIV-1 subtype C infection treated with ZDV\/ddI-containing ART in Southern Africa. Conference on retroviruses and opportunistic infections 2007","volume":"23","author":"Novitsky","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1002\/cyto.b.20383-BIB49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/510745","article-title":"Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails","volume":"44","author":"Sungkanuparph","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB50","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/01.qai.0000214807.98465.a2","article-title":"Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4 positive lymphocytes count in HIV-infected patients in the United States and Uganda","volume":"41","author":"Spacek","year":"2006","journal-title":"J Acquir Immun Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB51","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1097\/00002030-200310170-00008","article-title":"Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: The ANRS 12-26 study","volume":"17","author":"Diagbouga","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB52","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1086\/375369","article-title":"Monitoring of human immunodeficiency virus infection in resource-constrained countries","volume":"37","author":"Crowe","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1097\/00126334-200408150-00002","article-title":"An inexpensive, simple and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries","volume":"36","author":"Balakrishnan","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB54","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00126334-200102010-00017","article-title":"Comparative assessment of five alternative methods for CD4+ T-lymphocyte enumeration for implementation in developing countries","volume":"26","author":"Didier","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1128\/CDLI.3.4.371-373.1996","article-title":"Comparison of absolute CD4+ lymphocyte counts determined by enzyme immunoassay (TRAx CD4 test kit) and flow cytometry","volume":"3","author":"Moss","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB56","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1177\/135965350400900309","article-title":"Simplified volumetric flow cytometry allows feasible and accurate determination of CD4 T lymphocytes in immunodeficient patients worldwide","volume":"9","author":"Cassens","year":"2004","journal-title":"Antivir Ther"},{"key":"10.1002\/cyto.b.20383-BIB57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1128\/CDLI.12.1.224-227.2005","article-title":"Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting","volume":"12","author":"Imade","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB58","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.qai.0000160515.20581.ad","article-title":"Absolute CD4 T-cell counting in resource-poor settings: Direct volumetric measurements versus bead-based clinical flow cytometry instruments","volume":"39","author":"Dieye","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB59","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/CDLI.12.12.1416-1424.2005","article-title":"Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients","volume":"12","author":"Pattanapanyasat","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB60","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cyto.b.20093","article-title":"Comparison of two alternative methods for CD4+ T cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda","volume":"70B","author":"Karcher","year":"2006","journal-title":"Cytometry B Clin Cytometry"},{"key":"10.1002\/cyto.b.20383-BIB61","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.trstmh.2005.11.014","article-title":"The Partec CyFlow counter could provide an option for CD4+ T cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi","volume":"100","author":"Fryland","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1002\/cyto.b.20383-BIB62","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1479-5876-4-33","article-title":"Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting","volume":"4","author":"Zijenah","year":"2006","journal-title":"J Transl Med"},{"key":"10.1002\/cyto.b.20383-BIB63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/01.qai.0000242447.82403.c2","article-title":"Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia","volume":"43","author":"Lynen","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB64","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CVI.00416-06","article-title":"Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe","volume":"14","author":"Manasa","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1002\/cyto.b.20383-BIB65","first-page":"169","article-title":"Panleucogating as an accurate and affordable flow cytometric protocol to analyse lymphocyte subsets among HIV-positive patients on HAART treatment in Mozambique","volume":"19","author":"Ceffa","year":"2005","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1002\/cyto.b.20383-BIB66","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1128\/CDLI.2.5.623-625.1995","article-title":"A manual bead assay for the determination of absolute CD4+ and CD8+ lymphocyte counts in human immunodeficiency virus-infected individuals","volume":"2","author":"Carella","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1002\/cyto.b.20383-BIB67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1006\/clin.1995.1107","article-title":"Determination of CD4+ and CD8+ lymphocytes with the cytosphere assay: A comparative study with flow cytometry and the immunoalkaline phosphatase method","volume":"76","author":"Gernow","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1002\/cyto.b.20383-BIB68","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1097\/00002030-199312000-00004","article-title":"A rapid manual method for CD4+ T cell quantitation for use in developing countries","volume":"7","author":"Landay","year":"1993","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB69","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/qjmed\/89.7.505","article-title":"CD4 and total lymphocyte counts as predictors of HIV disease progression","volume":"89","author":"Post","year":"1996","journal-title":"QJM"},{"key":"10.1002\/cyto.b.20383-BIB70","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1086\/422722","article-title":"The search for a predictor of CD4 cell count continues: Total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting","volume":"39","author":"Akinola","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1002\/cyto.b.20383-BIB71","unstructured":"Akanbi M,Taiwo B,Welty L,Idoko J,Samson I,Gwamzhi N,Murphy R. Sensitivity of total lymphocyte count as a predictor of CD4 count in ARV naive HIV patient at JUTH, Jos, Nigeria. In: XVI International AIDS Conference, Toronto, 2006. Abstract MOPE0151."},{"key":"10.1002\/cyto.b.20383-BIB72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00002030-200306130-00005","article-title":"Total lymphocyte and hemoglobin combined in algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings","volume":"17","author":"Spacek","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/cyto.b.20383-BIB73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAI.0b013e318032385e","article-title":"Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings","volume":"44","author":"Chen","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1002\/cyto.b.20383-BIB74","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM200101183440302","article-title":"Discontinuation of secondary prophylaxis against Pneumocystis carinii pneumonia in patients with HIV infection who have a response to antiretroviral therapy","volume":"344","author":"Ledergerber","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Cytometry Part B: Clinical Cytometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcyto.b.20383","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/cyto.b.20383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T04:28:12Z","timestamp":1684124892000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cyto.b.20383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":74,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1002\/cyto.b.20383","relation":{},"ISSN":["1552-4949","1552-4957"],"issn-type":[{"value":"1552-4949","type":"print"},{"value":"1552-4957","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}